Skip to content
Lupin
-
Lupin recalls 2.5M prednisolone eye drop bottles in United States due to foreign substance concerns
The FDA has classified the action as a Class II recall, indicating that the affected product may cause temporary or medically reversible adverse health effects, although the likelihood of serious health consequences remains low.
-
Lupin secures first China NMPA approval with Oseltamivir launch
The product will be manufactured and commercialized to support treatment and prevention needs during influenza seasons, with an emphasis on improving availability for younger patients across China.